CliffBio
biologic

Betaseron

interferon beta-1b

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameBetaseron
Active ingredientinterferon beta-1b
Strength0.3MG
Dosage formFor Injection
RouteSubcutaneous
ModalityBiologic
Marketing statusRx

More from Bayer Healthcare

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.